TTrialPathMatch Me to Trials
← Back to trials
RecruitingAlzheimer Disease

Late Onset Alzheimer's Disease

Eligible age

55+ yrs

Accepts

All genders

Locations

11 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

Sponsor: Columbia University

You may qualify if…

  • Established diagnosis of definite or probable AD or have a diagnosis of a related neurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy Body Dementia (LBD) (will also recruit sporadic FTD and LBD) cases.
  • a living sibling with probable or possible AD;
  • a third living relative affected with AD (onset age 50 or older) or unaffected (60 or older);
  • participants in the proband's generation with an identified companion serving as an informant;
  • participants who have capacity to consent or participants lacking capacity to consent with a surrogate/proxy in place to provide consent.

You may not qualify if…

  • failure to identify an appropriate informant;
  • uncertainty of the clinical diagnosis of Alzheimer's disease or other related disorder;
  • discovery of additional diagnosis that could account for the clinical manifestations;
  • unwillingness to participate;
  • failure to identify a living sibling with AD or other related disorder (except in the cases of sporadic FTD and sporadic LBD);
  • participants lacking the capacity to consent who do not have a surrogate or proxy or next of kin to provide consent.

Where it's recruiting

District of Columbia

Washington D.C.

Florida

Miami

Illinois

Aurora

Indiana

Bloomington · Indianapolis

Minnesota

Rochester

Missouri

St Louis

New York

New York

Pennsylvania

Pittsburgh

Texas

Dallas

Washington

Seattle

Source: ClinicalTrials.gov · NCT05010603 · last updated 2026-05-18

Late Onset Alzheimer's Disease · TrialPath